Altamira Therapeutics Ltd. Interest Income Defined Benefit Plans
Altamira Therapeutics Ltd. (CYTOF) reported Interest Income Defined Benefit Plans of $62.08 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Income Statement › Other Income
ifrs-full:InterestIncomeDefinedBenefitPlans · last filed 2025-04-30
| Period end | Interest Income Defined Benefit Plans 12 month |
|---|---|
| 2024-12-31 | $62.08K 20-F · filed 2025-04-30 |
| 2023-12-31 | $79.92K 20-F · filed 2025-04-30 |